UK markets closed

Mineralys Therapeutics, Inc. (MLYS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.58-0.11 (-0.87%)
At close: 04:00PM EDT
12.58 0.00 (0.00%)
After hours: 06:10PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-90,798
-71,898
-29,799
-19,408
-3,426
Stock-based compensation
6,502
5,060
455
80
1
Change in working capital
5,270
-7,470
772
4,085
480
Other working capital
-87,596
-81,173
-29,221
-14,559
-2,463
Other non-cash items
-8,519
-6,865
-649
684
482
Net cash provided by operating activities
-87,537
-81,173
-29,221
-14,559
-2,463
Cash flows from investing activities
Purchases of investments
-308,614
-347,972
-71,759
0
-
Sales/maturities of investments
232,500
187,500
50,000
0
-
Net cash used for investing activities
-76,173
-160,472
-21,759
0
-
Cash flows from financing activities
Common stock issued
115,538
202,990
-
-
-
Common stock repurchased
-
-
-1,629
-
-20
Other financing activities
-
-
-1,629
-
-
Net cash used provided by (used for) financing activities
115,882
203,248
128,019
23,812
3,830
Net change in cash
-47,828
-38,397
77,039
9,253
1,367
Cash at beginning of period
138,246
87,701
10,662
1,409
42
Cash at end of period
90,418
49,304
87,701
10,662
1,409
Free cash flow
Operating cash flow
-87,537
-81,173
-29,221
-14,559
-2,463
Free cash flow
-87,596
-81,173
-29,221
-14,559
-2,463